Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Creon IR Low Dose	14
Overall Study	STARTED	Creon IR Medium Dose	14
Overall Study	STARTED	Creon IR High Dose	14
Overall Study	STARTED	Creon IR Maximum Dose	14
Overall Study	STARTED	Creon® (DR/GR)	14
Overall Study	COMPLETED	Creon IR Low Dose	14
Overall Study	COMPLETED	Creon IR Medium Dose	13
Overall Study	COMPLETED	Creon IR High Dose	14
Overall Study	COMPLETED	Creon IR Maximum Dose	13
Overall Study	COMPLETED	Creon® (DR/GR)	14
Overall Study	NOT COMPLETED	Creon IR Low Dose	0
Overall Study	NOT COMPLETED	Creon IR Medium Dose	1
Overall Study	NOT COMPLETED	Creon IR High Dose	0
Overall Study	NOT COMPLETED	Creon IR Maximum Dose	1
Overall Study	NOT COMPLETED	Creon® (DR/GR)	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02415959/flow